The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreaves Lansdown Regulatory News (HL.)

Share Price Information for Hargreaves Lansdown (HL.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,067.50
Bid: 1,067.00
Ask: 1,068.50
Change: -4.00 (-0.37%)
Spread: 1.50 (0.141%)
Open: 1,066.00
High: 1,069.50
Low: 1,063.50
Prev. Close: 1,071.50
HL. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FSA CONSULTATION PAPER ON PLATFORMS

18 Nov 2010 09:57

RNS Number : 4160W
Hargreaves Lansdown PLC
18 November 2010
 



 

PRESS RELEASE / INVESTOR & ANALYST BRIEFING

FSA CONSULTATION PAPER ON PLATFORMS

18 NOVEMBER 2010

Press Comment

Ian Gorham, Hargreaves Lansdown's Chief Executive said:

"We are satisfied with the outcome of the FSA's platform paper. The paper recognises the value of services such as those provided by Hargreaves Lansdown, which give clients the ability to access a huge choice of investments at low cost. At the same time it recognises the aggregation benefits product providers also derive from our services. The paper contains a number of initiatives which, if properly delivered, should benefit financial services retail clients. We do not perceive any threat to the Hargreaves Lansdown model from the paper. As we already offer most of the initiatives proposed by the FSA, such as re-registration, the cost implications for Hargreaves Lansdown should be very limited."

Hargreaves Lansdown provides the following more detailed response:

General overview

·; As an independent company, Hargreaves Lansdown supports the key potential outcomes for the Retail Distribution Review, particularly the provision of unbiased advice and promotion of investment choice.

 

·; We are satisfied with the consultation paper. There are no elements of the paper that give Hargreaves Lansdown cause for concern. We do not perceive any threat to the Hargreaves Lansdown model or sources of income.

 

·; We particularly note that the FSA has concluded platforms may continue to receive remuneration from product providers, recognising the benefits and services provided to these providers. We also note that execution-only (non-advised) business remains out of scope for most elements of the paper. We agree with these conclusions. Non-advised business represents over 85% of Hargreaves Lansdown Assets under Administration.

 

·; The paper sets out requirements for platforms to meet various administrative standards, such as providing re-registration facilities and information to unit holders. Hargreaves Lansdown already allows clients to re-register and transfer to other providers. We foresee very limited cost implications for our company from the paper.

 

·; We also welcome the FSA's intention to focus on more timely transfers of investments in the financial services industry. The current transfer processes across the financial services industry are often unnecessarily complex and slow - usually when involving outflows from non-platform companies - and cause frustration, cost and uncertainty for clients who are exercising choice over their own investments.

 

The Future of the Market and Pricing

 

·; It is possible the platform and advisory marketplace may reshape over the next few years. The RDR may contribute to this change. It is impossible for any organisation to predict those changes precisely, but we are confident that a platform of sufficient scale providing a high quality service such as our own shall continue to be successful and grow profitably.

 

·; Like many, we believe the requirement for adviser charging, coupled with an increasing trend for investors to conduct their own research using widely accessible sources of information may lead to a reduction in the number of Financial Advisers in the UK. Hargreaves Lansdown sees this as an opportunity to attract further substantial numbers of clients to the high quality, low-cost Vantage service where they can administer their own investments.

 

·; We note the FSA's comment that they "would be surprised if [annual management] charges were maintained at current levels." We understand the logic of their expectation of a fall, whilst noting market forces are the key driver of prices rather than regulatory change. Hargreaves Lansdown has been at the forefront of achieving improved pricing for clients over the years. However, we wait with interest to see if such changes will occur to the extent FSA envisage. For example, if the IFA population shrinks, fund managers may need to retain income to finance alternative distribution and advertising strategies. Therefore they may consider reducing charges, especially in the short term, imprudent. Hargreaves Lansdown is a highly profitable and well established platform. Some other platforms are yet to demonstrate their sustainability and do not have the same economies of scale. The charges some other platforms levy on product providers for their services may need to increase if they are to survive. Therefore the potential for flexibility in the pricing chain appears uncertain.

 

·; Assuming the main aspects of the Consultation Paper are adopted into the rules in due course, Hargreaves Lansdown shall watch market developments with interest and react accordingly. We believe the paper does not currently require any changes to our highly successful business model or our services to clients.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFEALSLTLII
Date   Source Headline
22nd Nov 20171:29 pmRNSDirector/PDMR Shareholding
8th Nov 20173:00 pmRNSDirector/PDMR Shareholding
6th Nov 20174:48 pmRNSDirector/PDMR Shareholding
3rd Nov 20173:30 pmRNSDirector/PDMR Shareholding
1st Nov 201711:30 amRNSDirector/PDMR Shareholding
25th Oct 20174:26 pmRNSDirector/PDMR Shareholding
13th Oct 20174:35 pmRNSDirector/PDMR Shareholding
11th Oct 20177:00 amRNSInterim Management Statement
5th Oct 20174:25 pmRNSHolding(s) in Company
29th Sep 20174:53 pmRNSHolding(s) in Company - TR-1 form
8th Sep 20171:35 pmRNSNotice of AGM
1st Sep 20179:30 amRNSBoard Committee changes
30th Aug 20173:03 pmRNSAnnual Financial Report
22nd Aug 201710:59 amRNSDirector/PDMR Shareholding
17th Aug 20174:54 pmRNSDirector/PDMR Shareholding
17th Aug 20174:52 pmRNSDirectorate Change
15th Aug 201711:00 amRNSDirector/PDMR Shareholding
15th Aug 20177:00 amRNSFinal Results
4th Aug 20177:00 amRNSRegulatory Capital and Dividend Policy Update
28th Jul 20171:47 pmRNSBoard Committee change
19th Jul 201711:21 amRNSNotice of Results
1st Jun 20174:33 pmRNSDirector/PDMR Shareholding
18th May 20171:17 pmRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSDirectorate Change
18th May 20177:00 amRNSTrading Statement
2nd May 201711:37 amRNSDirector/PDMR Shareholding
13th Apr 20173:16 pmRNSDirectorate Change
7th Apr 201711:31 amRNSDirectorate Change
5th Apr 20172:51 pmRNSDirector/PDMR Shareholding
10th Mar 20175:47 pmRNSDirector/PDMR Shareholding
7th Mar 20174:43 pmRNSResult of Meeting
9th Feb 20172:55 pmRNSDirectorate Change
8th Feb 20172:21 pmRNSPublication of Circular
8th Feb 20177:00 amRNSDividend Declaration
8th Feb 20177:00 amRNSHalf-year Report
25th Jan 201712:32 pmRNSDirectorate Change
9th Jan 201711:03 amRNSNotice of Interim Results
6th Dec 201610:01 amRNSHolding(s) in Company
14th Nov 20164:03 pmRNSResult of AGM
13th Oct 20167:00 amRNSTrading Statement
7th Oct 20163:52 pmRNSDirector/PDMR Shareholding
23rd Sep 201612:44 pmRNSDirector/PDMR Shareholding
19th Sep 201611:10 amRNSDirector/PDMR Shareholding
13th Sep 20165:38 pmRNSDirector/PDMR Shareholding
7th Sep 20164:46 pmRNSDirector/PDMR Shareholding
7th Sep 20167:00 amRNSDirectorate Change
7th Sep 20167:00 amRNSDividend Declaration
7th Sep 20167:00 amRNSFinal Results
8th Aug 201610:23 amRNSNotice of Results
8th Jul 20164:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.